Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Defects in Mitochondrial Biogenesis Drive Mitochondrial Alterations in PARKIN-Deficient Human Dopamine Neurons
Manoj Kumar, Jesús A. Acevedo-Cintrón, Aanishaa Jhaldiyal, et al.
Stem Cell Reports (2020) Vol. 15, Iss. 3, pp. 629-645
Open Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

Alzheimer’s disease and its treatment by different approaches: A review
Sukriti Srivastava, Razi Ahmad, Sunil Kumar Khare
European Journal of Medicinal Chemistry (2021) Vol. 216, pp. 113320-113320
Closed Access | Times Cited: 344
Mechanisms of mitochondrial respiratory adaptation
Christopher F. Bennett, Pedro Latorre‐Muro, Pere Puigserver
Nature Reviews Molecular Cell Biology (2022) Vol. 23, Iss. 12, pp. 817-835
Open Access | Times Cited: 156
Neuronal NLRP3 is a parkin substrate that drives neurodegeneration in Parkinson’s disease
Nikhil Panicker, Tae‐In Kam, Hu Wang, et al.
Neuron (2022) Vol. 110, Iss. 15, pp. 2422-2437.e9
Open Access | Times Cited: 133
The cell biology of Parkinson’s disease
Nikhil Panicker, Preston Ge, Valina L. Dawson, et al.
The Journal of Cell Biology (2021) Vol. 220, Iss. 4
Open Access | Times Cited: 111
Targeting Mitochondrial Impairment in Parkinson's Disease: Challenges and Opportunities
Jannik Prasuhn, Ryan L. Davis, Kishore R. Kumar
Frontiers in Cell and Developmental Biology (2021) Vol. 8
Open Access | Times Cited: 109
Mitochondrial dysfunction in Parkinson’s disease – a key disease hallmark with therapeutic potential
Martin T. Henrich, Wolfgang H. Oertel, D. James Surmeier, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 95
Crosstalk between mitochondrial biogenesis and mitophagy to maintain mitochondrial homeostasis
Lei Liu, Yanjun Li, Guo Chen, et al.
Journal of Biomedical Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 86
Mitochondrial Dysfunction in Parkinson’s Disease: From Mechanistic Insights to Therapy
Xiaoyan Gao, Tuo Yang, Ying Gu, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 75
Ameliorating Mitochondrial Dysfunction of Neurons by Biomimetic Targeting Nanoparticles Mediated Mitochondrial Biogenesis to Boost the Therapy of Parkinson's Disease
Qing Yin Zheng, Hanghang Liu, Hao Zhang, et al.
Advanced Science (2023) Vol. 10, Iss. 22
Open Access | Times Cited: 50
Mitochondrial Dysfunction and Parkinson’s Disease: Pathogenesis and Therapeutic Strategies
Sadegh Moradi Vastegani, Ava Nasrolahi, Shahab Ghaderi, et al.
Neurochemical Research (2023) Vol. 48, Iss. 8, pp. 2285-2308
Closed Access | Times Cited: 48
Cell biology of Parkinson's disease: Mechanisms of synaptic, lysosomal, and mitochondrial dysfunction
Sarah M. Brooker, G Naylor, Dimitri Krainc
Current Opinion in Neurobiology (2024) Vol. 85, pp. 102841-102841
Closed Access | Times Cited: 26
Cellular and molecular pathophysiology in the progression of Parkinson’s disease
Vandana Zaman, Donald C. Shields, Ramsha Shams, et al.
Metabolic Brain Disease (2021) Vol. 36, Iss. 5, pp. 815-827
Open Access | Times Cited: 75
PARK Genes Link Mitochondrial Dysfunction and Alpha-Synuclein Pathology in Sporadic Parkinson’s Disease
Wen Li, YuHong Fu, Glenda M. Halliday, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 70
PGC-1s in the Spotlight with Parkinson’s Disease
Elena Piccinin, Anna Maria Sardanelli, Peter Seibel, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 7, pp. 3487-3487
Open Access | Times Cited: 64
Mitophagy and reactive oxygen species interplay in Parkinson’s disease
Bin Xiao, Joshua Kuruvilla, Eng‐King Tan
npj Parkinson s Disease (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 52
Wireless Deep Brain Stimulation by Ultrasound-Responsive Molecular Piezoelectric Nanogenerators
Ping Chen, Cheng Chi, Xiaomei Yang, et al.
ACS Nano (2023) Vol. 17, Iss. 24, pp. 25625-25637
Closed Access | Times Cited: 24
PARIS farnesylation prevents neurodegeneration in models of Parkinson’s disease
Areum Jo, Yunjong Lee, Tae‐In Kam, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 604
Open Access | Times Cited: 53
Urolithin A protects dopaminergic neurons in experimental models of Parkinson's disease by promoting mitochondrial biogenesis through the SIRT1/PGC-1α signaling pathway
Jia Liu, Jingjing Jiang, Jingru Qiu, et al.
Food & Function (2021) Vol. 13, Iss. 1, pp. 375-385
Closed Access | Times Cited: 44
mtDNA Heteroplasmy at the Core of Aging-Associated Heart Failure. An Integrative View of OXPHOS and Mitochondrial Life Cycle in Cardiac Mitochondrial Physiology
Álvaro A. Elorza, Juan Pablo Soffia
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 43
Novel insights into Parkin-mediated mitochondrial dysfunction and neuroinflammation in Parkinson's disease
Sandro L. Pereira, Dajana Großmann, Sylvie Delcambre, et al.
Current Opinion in Neurobiology (2023) Vol. 80, pp. 102720-102720
Open Access | Times Cited: 21
Ameliorating Mitochondrial Dysfunction for the Therapy of Parkinson's Disease
Qing Yin Zheng, Hanghang Liu, Yifan Gao, et al.
Small (2024) Vol. 20, Iss. 29
Closed Access | Times Cited: 8
Parkin, a Parkinson's disease-associated protein, mediates the mitophagy that plays a vital role in the pathophysiology of major depressive disorder
Yi Zhang
Neurochemistry International (2024) Vol. 179, pp. 105808-105808
Closed Access | Times Cited: 8
α-Synuclein pathology as a target in neurodegenerative diseases
Hye-Jin Park, Tae‐In Kam, Valina L. Dawson, et al.
Nature Reviews Neurology (2024)
Closed Access | Times Cited: 7
Hypoxia Signaling in Parkinson’s Disease: There Is Use in Asking “What HIF?”
Laura Lestón Pinilla, Aslihan Ugun‐Klusek, Sergio Rutella, et al.
Biology (2021) Vol. 10, Iss. 8, pp. 723-723
Open Access | Times Cited: 36
Dysregulation of PGC-1α-Dependent Transcriptional Programs in Neurological and Developmental Disorders: Therapeutic Challenges and Opportunities
Laura J. McMeekin, Stephanie N. Fox, Stephanie M. Boas, et al.
Cells (2021) Vol. 10, Iss. 2, pp. 352-352
Open Access | Times Cited: 34
Page 1 - Next Page

Scroll to top